These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9118036)

  • 1. p53 and MDM2 alterations in osteosarcomas: correlation with clinicopathologic features and proliferative rate.
    Lonardo F; Ueda T; Huvos AG; Healey J; Ladanyi M
    Cancer; 1997 Apr; 79(8):1541-7. PubMed ID: 9118036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
    Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alterations of MDM2 and p53 genes in bone tumors].
    Zhou X; Gao L; Zhe X
    Zhonghua Bing Li Xue Za Zhi; 1997 Oct; 26(5):270-2. PubMed ID: 10374333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma.
    Park HR; Jung WW; Bertoni F; Bacchini P; Park JH; Kim YW; Park YK
    Pathol Res Pract; 2004; 200(6):439-45. PubMed ID: 15310147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of the p53, Rb and MDM2 genes in osteosarcoma.
    Miller CW; Aslo A; Won A; Tan M; Lampkin B; Koeffler HP
    J Cancer Res Clin Oncol; 1996; 122(9):559-65. PubMed ID: 8781571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of p53 and MDM2 gene expression in osteosarcoma with biotin-labelled in situ].
    Wang X; Wang S; Feng C
    Zhonghua Wai Ke Za Zhi; 1997 Mar; 35(3):178-80. PubMed ID: 10374529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws.
    Lopes MA; Nikitakis NG; Ord RA; Sauk J
    Oral Oncol; 2001 Oct; 37(7):566-71. PubMed ID: 11564577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.
    Mejia-Guerrero S; Quejada M; Gokgoz N; Gill M; Parkes RK; Wunder JS; Andrulis IL
    Genes Chromosomes Cancer; 2010 Jun; 49(6):518-25. PubMed ID: 20196171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of the p53, Rb and MDM2 genes in canine osteosarcoma.
    Mendoza S; Konishi T; Dernell WS; Withrow SJ; Miller CW
    Anticancer Res; 1998; 18(6A):4449-53. PubMed ID: 9891508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDM2 gene amplification in metastatic osteosarcoma.
    Ladanyi M; Cha C; Lewis R; Jhanwar SC; Huvos AG; Healey JH
    Cancer Res; 1993 Jan; 53(1):16-8. PubMed ID: 8416741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status.
    McCann AH; Kirley A; Carney DN; Corbally N; Magee HM; Keating G; Dervan PA
    Br J Cancer; 1995 May; 71(5):981-5. PubMed ID: 7734324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutation and absence of mdm2 amplification and Ki-ras mutation in 4-hydroxyamino quinoline 1-oxide induced transplantable osteosarcomas in rats.
    Kido A; Tsujiuchi T; Tsutsumi M; Takahama M; Okajima E; Kobitsu K; Miyauchi Y; Mii Y; Tamai S; Konishi Y
    Cancer Lett; 1997 Jan; 112(1):5-10. PubMed ID: 9029163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic implications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors.
    Yokoyama R; Schneider-Stock R; Radig K; Wex T; Roessner A
    Pathol Res Pract; 1998; 194(9):615-21. PubMed ID: 9793960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
    Flørenes VA; Maelandsmo GM; Forus A; Andreassen A; Myklebost O; Fodstad O
    J Natl Cancer Inst; 1994 Sep; 86(17):1297-302. PubMed ID: 8064888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
    Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 Mutation and MDM2 amplification in human soft tissue sarcomas.
    Leach FS; Tokino T; Meltzer P; Burrell M; Oliner JD; Smith S; Hill DE; Sidransky D; Kinzler KW; Vogelstein B
    Cancer Res; 1993 May; 53(10 Suppl):2231-4. PubMed ID: 8387391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas.
    Cordon-Cardo C; Latres E; Drobnjak M; Oliva MR; Pollack D; Woodruff JM; Marechal V; Chen J; Brennan MF; Levine AJ
    Cancer Res; 1994 Feb; 54(3):794-9. PubMed ID: 8306343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COPS3 amplification and clinical outcome in osteosarcoma.
    Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
    Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered patterns of MDM2 and TP53 expression in human bladder cancer.
    Lianes P; Orlow I; Zhang ZF; Oliva MR; Sarkis AS; Reuter VE; Cordon-Cardo C
    J Natl Cancer Inst; 1994 Sep; 86(17):1325-30. PubMed ID: 8064890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 and MDM2 in the development and progression of bladder cancer.
    Schmitz-Dräger BJ; Kushima M; Goebell P; Jax TW; Gerharz CD; Bültel H; Schulz WA; Ebert T; Ackermann R
    Eur Urol; 1997; 32(4):487-93. PubMed ID: 9412812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.